During the past decade, D N Greenwald Center conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 20 clinical trials were completed, i.e. on average, 2000% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 8 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "D N Greenwald Center" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 7 trials, followed by "National Cancer Institute (NCI)" with 5 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 3 trials sponsored, "Eastern Cooperative Oncology Group" with 2 trials sponsored and "NSABP Foundation Inc" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "D N Greenwald Center" #1 collaborator was "National Cancer Institute (NCI)" with 20 trials as a collaborator, "NRG Oncology" with 5 trials as a collaborator, "Cancer and Leukemia Group B" with 2 trials as a collaborator, "Aptuit" with 1 trials as a collaborator and "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "D N Greenwald Center" are "Breast Cancer" (3 trials), "Colorectal Cancer" (3 trials), "Lung Cancer" (3 trials), "Recurrent Cervical Carcinoma" (3 trials) and "Stage IVB Cervical Cancer" (3 trials). Many other conditions were trialed in "D N Greenwald Center" in a lesser frequency.

Most popular intervention types in "D N Greenwald Center" are "Drug" (23 trials), "Other" (13 trials), "Biological" (7 trials), "Radiation" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (6 trials), "Paclitaxel" (4 trials), "Laboratory Biomarker Analysis" (3 trials), "Bevacizumab" (2 trials) and "Carboplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "D N Greenwald Center" are 18 trials for "All" genders, 5 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "D N Greenwald Center". undefined are not yet recruiting, undefined are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in D N Greenwald Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in D N Greenwald Center, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".